Klebsiella Pneumoniae Sepsis Clinical Trial
Official title:
Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.
Nosocomial infections are increasing rapidly both internationally and domestically, especially carbapenem-resistant Klebsiella pneumoniae infections. However, there were still lack of evidence about the risk and prognosis in Taiwan. The choice of drug and related sensitivity test was also limited. We would analyze the infection risk, prognosis, and drug sensitivity of Klebsiella pneumoniae and focus on strategy to manage carbapenem-resistant Klebsiella pneumoniae infections.
| Status | Not yet recruiting |
| Enrollment | 200 |
| Est. completion date | March 2022 |
| Est. primary completion date | March 2022 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 21 Years to 100 Years |
| Eligibility | All adult patients (=18 years) with K. pneumoniae bloodstream infection were included. Patients were excluded if there was other recognized bacteremia within two weeks before or after the first episode of K. pneumoniae bloodstream infection. |
| Country | Name | City | State |
|---|---|---|---|
| Taiwan | National Taiwan University Hospital | Taipei |
| Lead Sponsor | Collaborator |
|---|---|
| National Taiwan University Hospital |
Taiwan,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | All-cause 28-day mortality | 2017-2019 |